Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy

The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis

(2016) Pedro N Aguiar et al.   Immunotherapy

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages

(2016) Thibault Vieira et al.   LUNG CANCER

Soluble Toll-like receptor 4 is a potential serum biomarker in non-small cell lung cancer

(2016) Feng Wei et al.   Oncotarget

TLR4/ROS/miRNA-21 pathway underlies lipopolysaccharide instructed primary tumor outgrowth in lung cancer patients

(2016) Xianqi Zhang et al.   Oncotarget

The Non–Small Cell Lung Cancer Immune Contexture. A Major Determinant of Tumor Characteristics and Patient Outcome

(2015) Romain Remark et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Classifying Cancers Based on T-cell Infiltration and PD-L1

(2015) Michele W.L. Teng et al.   CANCER RESEARCH

The prognostic value of PD-L1 expression for non-small cell lung cancer patients: A meta-analysis

(2015) A. Wang et al.   EJSO

The International Association for the Study of Lung Cancer Lung Cancer Staging Project

(2015) Hisao Asamura et al.   Journal of Thoracic Oncology

Predictive role of toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma

(2015) Laura K. Mäkinen et al.   ORAL ONCOLOGY

NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer

(2015) Xiyu Liu et al.   TUMOR BIOLOGY

Effect of TLR4 and B7-H1 on Immune Escape of Urothelial Bladder Cancer and its Clinical Significance

(2014) Yong-Hua Wang et al.   Asian Pacific Journal of Cancer Prevention

Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination

(2014) Zhenzhen Zhan et al.   Autophagy

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes

(2014) Ching-Yao Yang et al.   EUROPEAN JOURNAL OF CANCER

Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo

(2014) DAN LI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

TLR4 Activation Enhances the PD-L1–Mediated Tolerogenic Capacity of Colonic CD90+Stromal Cells

(2014) Ellen J. Beswick et al.   JOURNAL OF IMMUNOLOGY

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

Programmed Cell Death Ligand 1 Expression in Osteosarcoma

(2014) J. K. Shen et al.   Cancer Immunology Research

Modeling NSCLC Progression: Recent Advances and Opportunities Available

(2013) Ahmed Abbas Suleiman et al.   AAPS Journal

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer--Letter

(2013) L. Radvanyi et al.   CLINICAL CANCER RESEARCH

Influence of Postoperative Infectious Complications on Long-Term Survival of Lung Cancer Patients: A Population-Based Cohort Study

(2013) Amin Andalib et al.   Journal of Thoracic Oncology

Programmed death ligand-1 expression in non-small cell lung cancer

(2013) Vamsidhar Velcheti et al.   LABORATORY INVESTIGATION

Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells

(2013) S. Spranger et al.   Science Translational Medicine

Lung cancer: potential targets for immunotherapy

(2013) Eric Tartour et al.   Lancet Respiratory Medicine

FOXP3 and TLR4 protein expression are correlated in non-small cell lung cancer: Implications for tumor progression and escape

(2012) Hai-ying Fu et al.   ACTA HISTOCHEMICA

IL-17 promoted metastasis of non-small-cell lung cancer cells

(2012) Qinchuan Li et al.   IMMUNOLOGY LETTERS

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

(2012) Julie R. Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

(2012) J. M. Taube et al.   Science Translational Medicine

Differential Expression of Chemokine Receptors and their Roles in Cancer Imaging

(2012) Sridhar Nimmagadda   Frontiers in Oncology

The Long-term Impact of Surgical Complications After Resection of Stage I Nonsmall Cell Lung Cancer

(2011) Natasha M. Rueth et al.   ANNALS OF SURGERY

Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack

(2011) Hanying Bao et al.   CANCER BIOLOGY & THERAPY

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors

(2010) Céline Berthon et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence

(2010) Salomé González-Reyes et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion

(2009) Francis Rodier et al.   NATURE CELL BIOLOGY

Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer

(2009) Guan-Hong Shang et al.   RESPIRATORY MEDICINE

TLR4 Signaling Induces B7-H1 Expression Through MAPK Pathways in Bladder Cancer Cells

(2008) Yigang Qian et al.   CANCER INVESTIGATION

Increased expression of Toll-like receptors 4 and 9 in human lung cancer

(2008) Yan-Bei Zhang et al.   MOLECULAR BIOLOGY REPORTS

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells

(2007) Jean-Pierre Allam et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY